The British Association of Dermatologists recommends the use of TNF-α inhibitors on a case-by-case basis in pregnancy (Johansen et al., 2018), and the European Crohn’s and Colitis Organization has found that TNF-α inhibitors may be used safely until the third trimester (Johansen et al., 2018). The gene discussed is TNF; the disease is colitis.